Effect of lysozyme supplementation on growth performance, immune status, antioxidant function and intestinal microbiota in broilers. [PDF]
Wang T +7 more
europepmc +1 more source
This systematic review synthesizes prognostic models for survival and recurrence in resected non‐small cell lung cancer. While many models demonstrate moderate to good discrimination, few are externally validated and reporting quality is variable, limiting clinical applicability and highlighting the need for robust, transparent model development ...
Evangeline Samuel +4 more
wiley +1 more source
Dietary 5-aminolevulinic acid modulates gut microbiota, reduces oxidative stress, and enhances immune status in weanling piglets: An 8-week exploratory study. [PDF]
Ishikawa S +7 more
europepmc +1 more source
ABSTRACT Objective Status epilepticus (SE) is associated with significant mortality. Sleep architecture may reflect normal brain function. Impaired sleep architecture is associated with poorer outcomes in numerous conditions. Here we investigate the association of sleep architecture in continuous EEG (cEEG) with survival in SE.
Ran R. Liu +5 more
wiley +1 more source
Constructing a novel MPT-driven necrosis-associated gene set for predicting prognosis and immune status in skin cutaneous melanoma. [PDF]
Wenxian Y, Shuwen F.
europepmc +1 more source
Life‐Threatening Bradycardia in Anti‐NMDA‐Receptor Encephalitis and a Novel Use for Permanent Pacing
ABSTRACT Background Pediatric anti‐NMDA receptor encephalitis (pNMDARE) is an autoantibody‐mediated disorder that can cause severe autonomic dysfunction, including symptomatic bradycardia and asystole. Dysautonomia can last for years, making it very challenging to manage.
Sarah Tucker +9 more
wiley +1 more source
Analysis of serum inflammatory factors, immune status, and prognosis in patients with different degrees of femoral neck fractures. [PDF]
Weng H, Zhu L, Mei Z, Wu M, Xu Q.
europepmc +1 more source
AZOLLA (AZOLLA PINNATA) LEAVES EXTRACT SUPPLEMENTATION: EFFECT ON DIGESTIBILITY, BLOOD CONSTITUENTS, AND IMMUNITY STATUS OF OSSIMI SHEEP [PDF]
U. A. Nayel +4 more
openalex +1 more source
ABSTRACT Background Myasthenia gravis (MG) is an autoimmune disorder characterized by antibody‐mediated complement activation. Efgartigimod, a neonatal Fc receptor (FcRn) antagonist, is approved for treating generalized MG (gMG). However, its modulatory effects on upstream innate and adaptive immune cells remain largely unexplored.
Lei Jin +11 more
wiley +1 more source

